BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1818302)

  • 21. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
    Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.
    Rovira A; Urbano-Ispizua A; Cervantes F; Rozman M; Vives-Corrons JL; Montserrat E; Rozman C
    Ann Hematol; 1995 Mar; 70(3):129-33. PubMed ID: 7718641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 in chronic myeloid leukemia cell lines.
    Bi S; Hughes T; Bungey J; Chase A; de Fabritiis P; Goldman JM
    Leukemia; 1992 Aug; 6(8):839-42. PubMed ID: 1640738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia.
    Ge X; Tanaka K; Kamada N
    Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.
    Mashal R; Shtalrid M; Talpaz M; Kantarjian H; Smith L; Beran M; Cork A; Trujillo J; Gutterman J; Deisseroth A
    Blood; 1990 Jan; 75(1):180-9. PubMed ID: 1967214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia.
    Yamauchi K; Arimori S; Nagao T
    Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The abnormal p53 proteins expressed in CML cell lines are non-functional.
    Bi S; Lanza F; Goldman JM
    Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
    Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17.
    Rege-Cambrin G; Gaidano G; Serra A; Scaravaglio P; Guglielmelli T; Guerrasio A; Giovinazzo B; Saglio G
    Leukemia; 1994 Apr; 8 Suppl 1():S23-6. PubMed ID: 8152298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene alterations in human hematological malignancies: a review.
    Soussi T; Jonveaux P
    Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double P53 point mutation in extramedullary blast crisis of chronic myelogenous leukemia.
    Marasca R; Longo G; Luppi M; Barozzi P; Torelli G
    Leuk Lymphoma; 1994 Dec; 16(1-2):171-5. PubMed ID: 7696924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 gene rearrangements in chronic myelocytic leukemia.
    Hernández A; Hernández P; Corral L; Muñiz A; Alaez C; Espinosa E; Fernández O; Martinez G
    Ann Hematol; 1993 Feb; 66(2):81-3. PubMed ID: 8383542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
    Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G
    Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
    Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
    Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis.
    Marasca R; Luppi M; Barozzi P; Ferrari MG; Morselli M; Torelli G
    Leuk Lymphoma; 1996 Dec; 24(1-2):175-82. PubMed ID: 9049974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelomonocytic crisis with t(5;17) and a p53 mutation in a patient with chronic myelogenous leukemia.
    Nakagawa H; Fujii H; Nakai H; Inazawa J; Misawa S
    Am J Hematol; 1994 Apr; 45(4):335-40. PubMed ID: 8178805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
    Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
    Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.